Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 141

1.

Chemotherapy drug response in ovarian cancer cells strictly depends on a cathepsin D-Bax activation loop.

Castino R, Peracchio C, Salini A, Nicotra G, Trincheri NF, Démoz M, Valente G, Isidoro C.

J Cell Mol Med. 2009 Jun;13(6):1096-109. doi: 10.1111/j.1582-4934.2008.00435.x. Epub 2008 Jul 24.

PMID:
18657225
[PubMed - indexed for MEDLINE]
2.

Trichostatin A up-regulates p73 and induces Bax-dependent apoptosis in cisplatin-resistant ovarian cancer cells.

Muscolini M, Cianfrocca R, Sajeva A, Mozzetti S, Ferrandina G, Costanzo A, Tuosto L.

Mol Cancer Ther. 2008 Jun;7(6):1410-9. doi: 10.1158/1535-7163.MCT-08-0299.

PMID:
18566213
[PubMed - indexed for MEDLINE]
Free Article
3.

Cathepsin D-Bax death pathway in oxidative stressed neuroblastoma cells.

Castino R, Bellio N, Nicotra G, Follo C, Trincheri NF, Isidoro C.

Free Radic Biol Med. 2007 May 1;42(9):1305-16. Epub 2007 Jan 8.

PMID:
17395004
[PubMed - indexed for MEDLINE]
4.

Cisplatin-induced apoptosis proceeds by caspase-3-dependent and -independent pathways in cisplatin-resistant and -sensitive human ovarian cancer cell lines.

Henkels KM, Turchi JJ.

Cancer Res. 1999 Jul 1;59(13):3077-83. Erratum in: Cancer Res 2000 Feb 15;60(4):1150.

PMID:
10397248
[PubMed - indexed for MEDLINE]
Free Article
5.

Cisplatin- and paclitaxel-induced apoptosis of ovarian carcinoma cells and the relationship between bax and bak up-regulation and the functional status of p53.

Jones NA, Turner J, McIlwrath AJ, Brown R, Dive C.

Mol Pharmacol. 1998 May;53(5):819-26.

PMID:
9584207
[PubMed - indexed for MEDLINE]
Free Article
6.

Involvement of cathepsin D in chemotherapy-induced cytochrome c release, caspase activation, and cell death.

Emert-Sedlak L, Shangary S, Rabinovitz A, Miranda MB, Delach SM, Johnson DE.

Mol Cancer Ther. 2005 May;4(5):733-42.

PMID:
15897237
[PubMed - indexed for MEDLINE]
Free Article
7.

Lysosomal destabilization and cathepsin B contributes for cytochrome c release and caspase activation in embelin-induced apoptosis.

Joy B, Sivadasan R, Abraham T E, John M, Sobhan PK, Seervi M, T R S.

Mol Carcinog. 2010 Apr;49(4):324-36. doi: 10.1002/mc.20599.

PMID:
19943316
[PubMed - indexed for MEDLINE]
8.

Resistance to chemotherapy-induced apoptosis via decreased caspase-3 activity and overexpression of antiapoptotic proteins in ovarian cancer.

Yang X, Zheng F, Xing H, Gao Q, Wei W, Lu Y, Wang S, Zhou J, Hu W, Ma D.

J Cancer Res Clin Oncol. 2004 Jul;130(7):423-8.

PMID:
15156398
[PubMed - indexed for MEDLINE]
9.

[Chemotherapy resistance induced by interleukin-6 in ovarian cancer cells and its signal transduction pathways].

Wang Y, Li LZ, Ye L, Niu XL, Liu X, Zhu YQ, Sun WJ, Liang YJ.

Zhonghua Fu Chan Ke Za Zhi. 2010 Sep;45(9):691-8. Chinese.

PMID:
21092551
[PubMed - indexed for MEDLINE]
10.
11.

Tumor necrosis factor-related apoptosis-inducing ligand activates a lysosomal pathway of apoptosis that is regulated by Bcl-2 proteins.

Werneburg NW, Guicciardi ME, Bronk SF, Kaufmann SH, Gores GJ.

J Biol Chem. 2007 Sep 28;282(39):28960-70. Epub 2007 Aug 8.

PMID:
17686764
[PubMed - indexed for MEDLINE]
Free Article
12.

Curcumin-induced apoptosis in ovarian carcinoma cells is p53-independent and involves p38 mitogen-activated protein kinase activation and downregulation of Bcl-2 and survivin expression and Akt signaling.

Watson JL, Greenshields A, Hill R, Hilchie A, Lee PW, Giacomantonio CA, Hoskin DW.

Mol Carcinog. 2010 Jan;49(1):13-24. doi: 10.1002/mc.20571.

PMID:
19676105
[PubMed - indexed for MEDLINE]
13.

Time-dependent changes in factors involved in the apoptotic process in human ovarian cancer cells as a response to cisplatin.

Kolfschoten GM, Hulscher TM, Schrier SM, van Houten VM, Pinedo HM, Boven E.

Gynecol Oncol. 2002 Mar;84(3):404-12.

PMID:
11855878
[PubMed - indexed for MEDLINE]
14.

Combination effect of adenovirus-mediated pro-apoptotic bax gene transfer with cisplatin or paclitaxel treatment in ovarian cancer cell lines.

Tsuruta Y, Mandai M, Konishi I, Kuroda H, Kusakari T, Yura Y, Hamid AA, Tamura I, Kariya M, Fujii S.

Eur J Cancer. 2001 Mar;37(4):531-41.

PMID:
11267864
[PubMed - indexed for MEDLINE]
15.

BARD1 translocation to mitochondria correlates with Bax oligomerization, loss of mitochondrial membrane potential, and apoptosis.

Tembe V, Henderson BR.

J Biol Chem. 2007 Jul 13;282(28):20513-22. Epub 2007 May 17.

PMID:
17510055
[PubMed - indexed for MEDLINE]
Free Article
16.

Over-expression of PTEN sensitizes human ovarian cancer cells to cisplatin-induced apoptosis in a p53-dependent manner.

Yan X, Fraser M, Qiu Q, Tsang BK.

Gynecol Oncol. 2006 Aug;102(2):348-55. Epub 2006 Mar 20.

PMID:
16545436
[PubMed - indexed for MEDLINE]
17.

[Role of apoptosis-associated genes and caspase-3 in cisplatin-resistant human ovarian cancer cell lines].

Yang XK, Xing H, Zheng F, Gao QL, Wang W, Lu YP, Ma D.

Zhonghua Fu Chan Ke Za Zhi. 2003 Mar;38(3):158-61. Chinese.

PMID:
12816691
[PubMed - indexed for MEDLINE]
18.

Mitochondrial membrane permeabilization is a critical step of lysosome-initiated apoptosis induced by hydroxychloroquine.

Boya P, Gonzalez-Polo RA, Poncet D, Andreau K, Vieira HL, Roumier T, Perfettini JL, Kroemer G.

Oncogene. 2003 Jun 19;22(25):3927-36.

PMID:
12813466
[PubMed - indexed for MEDLINE]
19.

Oncolytic herpes simplex virus-1 lacking ICP34.5 induces p53-independent death and is efficacious against chemotherapy-resistant ovarian cancer.

Coukos G, Makrigiannakis A, Kang EH, Rubin SC, Albelda SM, Molnar-Kimber KL.

Clin Cancer Res. 2000 Aug;6(8):3342-53.

PMID:
10955822
[PubMed - indexed for MEDLINE]
Free Article
20.

Association between cisplatin resistance and mutation of p53 gene and reduced bax expression in ovarian carcinoma cell systems.

Perego P, Giarola M, Righetti SC, Supino R, Caserini C, Delia D, Pierotti MA, Miyashita T, Reed JC, Zunino F.

Cancer Res. 1996 Feb 1;56(3):556-62.

PMID:
8564971
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk